A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
about
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patientsConnexin 43 astrocytopathy linked to rapidly progressive multiple sclerosis and neuromyelitis opticaAntibody to aquaporin 4 in the diagnosis of neuromyelitis opticaAnti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotypeNeuromyelitis optica pathogenesis and aquaporin 4The history of neuromyelitis opticaAstrocytes differentially respond to inflammatory autoimmune insults and imbalances of neural activity.Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumabDiagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteriaAquaporin 4 and neuromyelitis opticaDiagnosis of inflammatory demyelination in biopsy specimens: a practical approachIgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channelDemyelinating diseasesNeuroimmunological Implications of AQP4 in AstrocytesClinical proteomics of enervated neuronsThe Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future PerspectivesB Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized InflammationWhat do we know about brain contrast enhancement patterns in neuromyelitis optica?Hypersensitivity Responses in the Central Nervous SystemMultiple sclerosis in India: An overviewTherapy of NMO spectrum disordersNeuromyelitis optica spectrum disorders: An updateAntibodies as Mediators of Brain PathologyFollicular Helper CD4+ T Cells in Human Neuroautoimmune Diseases and Their Animal ModelsAquaporin-4 autoimmunityUpdate on biomarkers in neuromyelitis opticaB Cells and Autoantibodies in Multiple SclerosisInternational consensus diagnostic criteria for neuromyelitis optica spectrum disordersThe use of flow cytometry to assess a novel drug efficacy in multiple sclerosisAtypical presentations of neuromyelitis opticaDevelopment, maintenance and disruption of the blood-brain barrierThe Neuroepithelium Disruption Could Generate Autoantibodies against AQP4 and Cause Neuromyelitis Optica and HydrocephalusSCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobankingApplications of SPR for the characterization of molecules important in the pathogenesis and treatment of neurodegenerative diseasesEpidemiology of neuromyelitis optica in the world: a systematic review and meta-analysisHumoral-targeted immunotherapies in multiple sclerosisChallenges and opportunities in designing clinical trials for neuromyelitis opticaPositive or negative involvement of heat shock proteins in multiple sclerosis pathogenesis: an overviewImmunology of neuromyelitis optica: a T cell-B cell collaborationMolecular pathogenesis of neuromyelitis optica
P2860
Q21093230-4A1755A4-888A-4F14-9822-5D51D78819D4Q21132530-347376BF-718A-47FC-BF98-F18FF0A25EC8Q21144670-62F4268A-CACC-4634-9653-233B237E8AA8Q21146662-0C80A6BA-F58D-4CC0-B345-96FC42BEF433Q21245240-D95DD89F-716E-4835-B18C-7406679CD7C8Q21245248-0F059D2B-90F8-44B2-A8A6-BA40A11756D0Q22001061-1E8571F7-E87A-4619-B415-50334D3C9B86Q24598109-1B031E72-6DCC-418E-810B-A97E6914E4E0Q24605493-0FB409AE-A6F3-449E-B42F-95C917B978A6Q24613666-450784D8-3AC8-4520-A0FC-9D8FA4800080Q24642895-C651B95D-ACDD-44CD-BC5A-5B715F6FBD68Q24646531-38A2CE55-5C49-4F59-9836-8F9BD09164D4Q24676347-83D529C9-7C55-4EDB-82A6-1839ADF40C07Q26741610-A08F9913-403B-4C2A-BF89-6952A827BFB9Q26752052-3BF8AF8B-9BBA-41D6-8CA1-F07AD7F123F1Q26767391-9FA10F85-C51B-44EA-A9BF-FA094430F14BQ26770852-A541279F-6AF1-462A-B66F-F5C2159CFCDBQ26776278-66D76EC4-1C5F-4CF9-8719-9A0DA1543A70Q26779177-DED39A28-EF3D-4DCB-BC4F-C0D535CDDF55Q26779908-B984337E-0E77-4DFD-9C9D-5E9EC754254BQ26779910-7870DD8D-060B-45AB-97B6-3BC4B4652517Q26779913-D0F2CA23-540A-44AA-B9F4-50B7E1A71084Q26780374-413594DF-7B27-4424-BECA-950500D9FABEQ26795577-EC3F0204-5413-4887-AE7A-C0B9468793A7Q26799559-9235D895-24F9-437B-B8A4-551ED6F48924Q26799789-83A70236-D613-49E6-95AA-80878914019CQ26801386-5FEE4A8F-8A45-4D0E-82FE-255B3BD41F9FQ26824579-B6F24E37-291E-453B-BCDC-BC19C208068BQ26824619-7AECF0D4-6132-4037-B1EC-5830FBE9926DQ26827156-1F50C7BA-6352-4C80-9F54-C6546CC856FFQ26829668-B0B45E32-8EC5-43A2-A1F1-E6BDAA046040Q26852499-3B931230-B3CF-42A7-941B-BBCD39F5CDDDQ26853573-03995699-4A14-4F4C-92D8-36A723AB2E57Q26860077-BAEA5A2E-5EC9-4223-AD30-E556F5DFB8FBQ26861381-AB024856-0B12-4EBF-BA74-1AFFB541BC2EQ26865971-46237504-57A2-4AC2-BE05-173CD26B1E97Q26999708-D9D19317-41D5-475C-83F1-FBDBB9CBF2A3Q27000682-4CE8034E-990F-420F-8808-763FDC9E3062Q27016045-2ABCF447-CD1E-460B-9138-5775909D29D8Q27021535-775F982F-ADB6-4FBC-A455-8293A63135B1
P2860
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
@ast
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
@en
type
label
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
@ast
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
@en
prefLabel
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
@ast
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
@en
P2093
P3181
P1433
P1476
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
@en
P2093
Brian G Weinshenker
Claudia F Lucchinetti
Dean M Wingerchuk
Kazuo Fujihara
Sean J Pittock
Thomas J Kryzer
Vanda A Lennon
P304
P3181
P356
10.1016/S0140-6736(04)17551-X
P407
P577
2004-12-01T00:00:00Z